Label: RAYDERM HYDRATING TONER- glycerin toner liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated October 11, 2018

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Glycerin (2.5%) - Skin Protectact

  • INACTIVE INGREDIENT

    Purified Water, Propanediol, Dipropylene, Methyl Gluceth-20, Glycereth-26, Glycerin, Pentylene Glycol, Betaine, C12-14 Pareth-12, Trehalose, Salvia Hispanica Seed Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Polyquaternium-51, Sodium Citrate, Sea Buckthorn Water, Butylene Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Citric Acid, Sodium Palmitoyl Proline, Nymphaea Tetragona Flower Extract, Green tea Extract, Black Rice Bran Extract, Cucumber Extract, Caprylyl Glycol, Fragrance

  • PURPOSE

    Skin Protectact

  • WARNINGS

    Precautions of Use
    1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
    2) Refrain from using on wound sites.
    3) Storage and handling precautions:
    i) Keep out of reach of children.
    ii) Keep away from direct sunlight

  • KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Apply the toner on the skin and spread evenly.

  • DOSAGE & ADMINISTRATION

    Apply the toner on the skin and spread evenly.

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    RAYDERM HYDRATING TONER 
    glycerin toner liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72543-004
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin6.25 g  in 250 mL
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    DIPROPYLENE GLYCOL (UNII: E107L85C40)  
    METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
    GLYCERETH-26 (UNII: NNE56F2N14)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    BETAINE (UNII: 3SCV180C9W)  
    C12-14 PARETH-12 (UNII: M0LJS773XW)  
    TREHALOSE (UNII: B8WCK70T7I)  
    SALVIA HISPANICA SEED (UNII: NU0OLX06F8)  
    CENTELLA ASIATICA (UNII: 7M867G6T1U)  
    POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7) (UNII: EL9825H96J)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO)  
    NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72543-004-01250 mL in 1 PACKAGE; Type 0: Not a Combination Product10/11/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/11/2018
    Labeler - VORY MEDICAL. Inc (694721104)
    Registrant - VORY MEDICAL. Inc (694721104)
    Establishment
    NameAddressID/FEIBusiness Operations
    VORY MEDICAL. Inc694721104manufacture(72543-004)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!